Key Takeaways Strategic price adjustments and brand enhancements in the Food segment may counter raw material cost pressures, boosting revenue and margins. Expansion in B2B and international markets, coupled with production optimization, is likely to drive revenue growth and profitability.
Meiji Holdings Co., Ltd., through its subsidiaries, engages in the manufacture and sale of dairy products, confectionery food products and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceuticals. The Food segment provides yogurt, milk, beverages, cheese, butter, margarine, cream, ice cream, prepared food, chocolate, gummy candy, sports nutrition, infant milk, liquid food, beauty products, feed, sugar, and corn sweeteners. The Pharmaceutical segment offers drugs for infectious and central nervous system disorders, vaccines, blood plasma products, generic drugs, and animal health products. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.
